Thryv Therapeutics Inc. Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 4, 2024) - Thryv Therapeutics Inc., a Montreal based biotechnology company pioneering a precision medicine approach to treat indications including Congenital Long QT Syndrome (LQTS), atrial fibrillation, and heart failure, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-04 2:40 PM EDT
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 3, 2024) - Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-03 7:05 AM EDT
Pharmascience Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 3, 2024) - Pharmascience Inc., the largest Canadian-owned pharmaceutical company and a leader in the Canadian generic market, will be participating in the 2024 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 16 and 17 at the Metro Toronto Convention Centre. Dates:Tuesday April 16, 2024-Wednesday April 17, 2024
2024-04-03 7:00 AM EDT
Bloom Burton & Co. Announces the 2024 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2024) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2024 Bloom Burton Award and to open nomination submissions. Nominations may be submitted by the public at large on or before March 22, 2024. Three finalists for the 2024 Bloom Burton Award will be announced at the 2024 Bloom Burton & Co. Healthcare Investor Conference, taking place at the Metro Toronto Convention Centre on April 16-17, 2024.
2024-01-25 7:00 AM EST
Stephen Dilly Receives the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 29, 2023) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Stephen Dilly, former Chief Executive Officer of Sierra Oncology, as the recipient of the 2023 Bloom Burton Award. 2023 Bloom Burton Award Winner Stephen Dilly, former Chief Executive Officer of Sierra OncologyTo view an enhanced
2023-09-29 7:12 AM EDT
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public offering of the Corporation by way of a short form prospectus dated May 9, 2023. Bloom Burton purchased the Shares at a price of $0.50 per Share for total consideration of $726,535 and its affiliate acquired the Compensation...
2023-05-17 5:29 PM EDT
Three Finalists Announced for the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 4, 2023) - Bloom Burton & Co. is pleased to announce the finalists for the 2023 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2023, in alphabetical order, are: Stephen Dilly, former President and Chief Executive Officer, Sierra Oncology Ian Mortimer, President and Chief Executive Officer, Xenon...
2023-05-04 7:00 AM EDT
BetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - BetterLife Pharma (CSE: BETR), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 20
2023-04-24 8:00 AM EDT
OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference
Quebec City, Quebec--(Newsfile Corp. - April 20, 2023) - OpSens (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-20 9:00 AM EDT
Adaptiiv Medical Technologies Inc. to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Halifax, Nova Scotia--(Newsfile Corp. - April 20, 2023) - Adaptiiv Medical Technologies Inc., (Adaptiiv), an FDA cleared medical device software company, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-20 8:00 AM EDT
Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 18, 2023) - Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre.Dates:Tuesday April 25, 2023 and Wednesday Apri
2023-04-18 5:00 PM EDT
Theratechnologies to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 18, 2023) - Theratechnologies (NASDAQ: THTX) (TSX: TH), a biopharmaceutical company focused on the development and commercialization of innovative therapies, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023-Wednesday April 26, 2023
2023-04-18 7:30 AM EDT
Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Tuesday April 25, 2023 at 2:30pm ET at the Metro Toronto Convention Centre in Toronto. Grey Wolf management will also be available for one-on-one meetings during both days of the...
2023-04-13 4:30 PM EDT
Congruence Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 12, 2023) - Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 25 and 26 at the Metro Toronto Convention Centre. Dates:Tuesday April 25, 2023
2023-04-12 8:00 AM EDT
Bloom Burton & Co. Announces the 2023 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2023) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2023 Bloom Burton Award. In addition, Bloom Burton is also announcing that this year's Bloom Burton Award Gala will be held at the Four Seasons Hotel Toronto on Thursday, September 28, 2023. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada's innovative...
2023-01-25 7:30 AM EST
Bloom Burton & Co. Inc. Announces Holdings in NeuPath Health Inc.
Toronto, Ontario--(Newsfile Corp. - November 25, 2022) - Bloom Burton & Co. Inc. announces that 1,000 compensation options (Options) of NeuPath Health Inc. expired unexercised on December 3, 2021, and combined with prior treasury issuances of common shares (Shares) of NeuPath Health, and the expiry of 66,250 Share purchase warrants (Warrants) resulted in a decrease of beneficial holdings to below 10% of the outstanding Shares.Prior to the expiry of the Options, Bloom Burton, beneficially owned 4,425,000 Shares, 1,000 Options and...
2022-11-25 5:30 PM EST
Pieter Cullis Receives the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 30, 2022) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom Burton Award. Pieter Cullis led the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics at Acuitas Therapeutics. The result of a lifetime of dedicated research driven by scientific curiosity, LNP delivery systems are a critical technology that help to accelerate, among other life-saving therapies, mRNA vaccine development....
2022-09-30 7:27 AM EDT
Three Finalists Announced for the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Bloom Burton & Co. is pleased to announce the finalists for the 2022 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2022, in alphabetical order, are: Frank Baylis, Executive Chairman, and Kris Shah, President, Baylis Medical TechnologiesPieter Cullis, Co-Founder and Chairman, Acuitas Therapeutics Jan...
2022-05-10 7:07 AM EDT
Bloom Burton & Co. Announces the 2022 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 25, 2022) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2022 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 29, 2022. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's innovative healthcare industry in...
2022-01-25 7:00 AM EST
The Bloom Burton Healthcare Lending Trust Named Winner in 2021 Canadian Hedge Fund Awards
Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - The Bloom Burton Healthcare Lending Trust (the "Fund") was recognized for the best 5-year track record in the private debt category at the 2021 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund as well as the Bloom Burton Canadian Healthcare Fund LP and the Bloom Burton Canadian Healthcare (RSP) Fund, alternative investment funds that focus on investments...
2021-10-20 7:00 AM EDT